Cargando…

New small-molecule drug design strategies for fighting resistant influenza A

Influenza A virus is the major cause of seasonal or pandemic flu worldwide. Two main treatment strategies–vaccination and small molecule anti-influenza drugs are currently available. As an effective vaccine usually takes at least 6 months to develop, anti-influenza small molecule drugs are more effe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Zuyuan, Lou, Kaiyan, Wang, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4629447/ https://www.ncbi.nlm.nih.gov/pubmed/26579472 http://dx.doi.org/10.1016/j.apsb.2015.07.006

Ejemplares similares

Small Molecule Inhibitors in the Treatment of Rheumatoid Arthritis and Beyond: Latest Updates and Potential Strategy for Fighting COVID-19
por: Massalska, Magdalena, et al.
Publicado: (2020)

Small Ones to Fight a Big Problem—Intervention of Cancer Metastasis by Small Molecules
por: Kobelt, Dennis, et al.
Publicado: (2020)

Fighting antibiotic resistance—strategies and (pre)clinical developments to find new antibacterials
por: Walesch, Sebastian, et al.
Publicado: (2022)

New pharmacological strategies to fight enveloped viruses
por: Wisskirchen, Karin, et al.
Publicado: (2014)

Promising Drug Candidates and New Strategies for Fighting against the Emerging Superbug Candida auris
por: Billamboz, Muriel, et al.
Publicado: (2021)

Emerging drug design strategies in anti-influenza drug discovery
por: Liu, Chuanfeng, et al.
Publicado: (2023)

Available influenza vaccines: immunization strategies, history and new tools for fighting the disease
por: Barberis, I., et al.
Publicado: (2016)

Antibiotics and Antimicrobials Resistance: Mechanisms and New Strategies to Fight Resistant Bacteria
por: Muller, Cécile
Publicado: (2022)

Fluoroquinolones Hybrid Molecules as Promising Antibacterial Agents in the Fight against Antibacterial Resistance
por: Lungu, Ioana-Andreea, et al.
Publicado: (2022)

Fighting Drug Resistance through the Targeting of Drug-Tolerant Persister Cells
por: De Conti, Giulia, et al.
Publicado: (2021)

Nanotechnology – a robust tool for fighting the challenges of drug resistance in non-small cell lung cancer
por: Gorachinov, Filip, et al.
Publicado: (2023)

Nanocarrier drug resistant tumor interactions: novel approaches to fight drug resistance in cancer
por: Benko, Aleksandra, et al.
Publicado: (2021)

Metal–Peptide Complexes as Promising Antibiotics to Fight Emerging Drug Resistance: New Perspectives in Tuberculosis
por: Di Natale, Concetta, et al.
Publicado: (2020)

Valorization of Winemaking By-Products as a Novel Source of Antibacterial Properties: New Strategies to Fight Antibiotic Resistance
por: Silva, Adriana, et al.
Publicado: (2021)

Fighting resistance: post-PARP inhibitor treatment strategies in ovarian cancer
por: Veneziani, Ana C., et al.
Publicado: (2023)

A new strategy to fight antimicrobial resistance: the revival of old antibiotics
por: Cassir, Nadim, et al.
Publicado: (2014)

Applications of Cryo-EM in small molecule and biologics drug design
por: Lees, Joshua A., et al.
Publicado: (2021)

Structure and Activities of the NS1 Influenza Protein and Progress in the Development of Small-Molecule Drugs
por: Kim, Hyeon Jin, et al.
Publicado: (2021)

Small Molecule Inhibitors of Influenza Virus Entry
por: Chen, Zhaoyu, et al.
Publicado: (2021)

Strategies for fighting pandemic virus infections: Integration of virology and drug delivery
por: Nakamura, Takashi, et al.
Publicado: (2022)

Metabolic Remodelling: An Accomplice for New Therapeutic Strategies to Fight Lung Cancer
por: Mendes, Cindy, et al.
Publicado: (2019)

Next-Generation Antimalarial Drugs: Hybrid Molecules as a New Strategy in Drug Design
por: Muregi, Francis W, et al.
Publicado: (2010)

Plazomicin: a new aminoglycoside in the fight against antimicrobial resistance
por: Clark, Justin A., et al.
Publicado: (2020)

Statins: a repurposed drug to fight cancer
por: Jiang, Wen, et al.
Publicado: (2021)

In Silico Approach for Phytocompound-Based Drug Designing to Fight Efflux Pump-Mediated Multidrug-Resistant Mycobacterium tuberculosis
por: Biswas, Santasree Sarma, et al.
Publicado: (2021)

New drugs engineered to fight asthma.
por: Susman, E
Publicado: (2000)

Breaking the Mold: New Strategies for Fighting Aflatoxins
por: Schmidt, Charles W.
Publicado: (2013)

Designing strategies of small-molecule compounds for modulating non-coding RNAs in cancer therapy
por: Zhao, Rongyan, et al.
Publicado: (2022)

Structure-based drug design of a new chemical class of small molecules active against influenza A nucleoprotein in vitro and in vivo
por: Fedichev, Peter, et al.
Publicado: (2011)

Selected strategies to fight pathogenic bacteria
por: Plotniece, Aiva, et al.
Publicado: (2023)

Antimicrobial Drugs in Fighting against Antimicrobial Resistance
por: Cheng, Guyue, et al.
Publicado: (2016)

Laser Optofluidics in Fighting Multiple Drug Resistance
por: Karapantsios, Thodoris D.
Publicado: (2018)

Targeted therapies in breast cancer: New challenges to fight against resistance
por: Masoud, Viviana, et al.
Publicado: (2017)

Bacteriocins, Potent Antimicrobial Peptides and the Fight against Multi Drug Resistant Species: Resistance Is Futile?
por: Meade, Elaine, et al.
Publicado: (2020)

Nanomedicine as a strategy to fight thrombotic diseases
por: Varna, Mariana, et al.
Publicado: (2015)

Phage Products for Fighting Antimicrobial Resistance
por: Huang, Yuanling, et al.
Publicado: (2022)

Cyclobutanes in Small‐Molecule Drug Candidates
por: van der Kolk, Marnix R., et al.
Publicado: (2022)

Strategies for Improving Small-Molecule Biosensors in Bacteria
por: Miller, Corwin A., et al.
Publicado: (2022)

In Silico Drug Design and Discovery: Big Data for Small Molecule Design
por: Cerchia, Carmen, et al.
Publicado: (2022)

New Strategies to Fight against Sarcopenia at Old Age
por: Meynial-Denis, Dominique, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_d6db7gmbg0m3eburravdiuib0q